Technical Support
(877) SEPAX-US, press 3 TechSupport@sepax-tech.com |
|
Search Results
Product
Zenix SEC-300 - View more details | Sign In to see pricing, or order online |
Made of 3 µm silica particles, Zenix SEC packing is a breakthrough technology for size exclusion chromatography. |
Part Number | Phase | Particle Size | Pore Size | ID×Length | Buy or Quote |
---|---|---|---|---|---|
213300-10005 | Zenix SEC-300 | 3 µm | 300 Å | 10.0×50mm | |
213300-10015 | Zenix SEC-300 | 3 µm | 300 Å | 10.0×150mm | |
213300-10030 | Zenix SEC-300 | 3 µm | 300 Å | 10.0×300mm | |
213300-1005 | Zenix SEC-300 | 3 µm | 300 Å | 1.000×50mm | |
213300-1030 | Zenix SEC-300 | 3 µm | 300 Å | 1.000×300mm | |
213300-2105 | Zenix SEC-300 | 3 µm | 300 Å | 2.1×50mm | |
213300-21205 | Zenix SEC-300 | 3 µm | 300 Å | 21.2×50mm | |
213300-21230 | Zenix SEC-300 | 3 µm | 300 Å | 21.2×300mm | |
213300-2130 | Zenix SEC-300 | 3 µm | 300 Å | 2.1×300mm | |
213300-4605 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×50mm | |
213300-4615 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×150mm | |
213300-4625 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×250mm | |
213300-4630 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×300mm | |
213300-7805 | Zenix SEC-300 | 3 µm | 300 Å | 7.8×50mm | |
213300-7815 | Zenix SEC-300 | 3 µm | 300 Å | 7.8×150mm | |
213300-7820 | Zenix SEC-300 | 3 µm | 300 Å | 7.8×200mm | |
213300-7830 | Zenix SEC-300 | 3 µm | 300 Å | 7.8×300mm | |
213300LS-4615 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×150mm | |
213300LS-4630 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×300mm | |
213300LS-7815 | Zenix SEC-300 | 3 µm | 300 Å | 7.8×150mm | |
213300LS-7830 | Zenix SEC-300 | 3 µm | 300 Å | 7.8×300mm | |
213300P-4605 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×50mm | |
213300P-4630 | Zenix SEC-300 | 3 µm | 300 Å | 4.6×300mm |
Application
MAb Innovator vs. its Biosimilar on Zenix SEC and Antibodix WCX - View application note |
Reproducibility for MAb Analysis on Zenix SEC - View application note |
MAb High Resolution by Zenix SEC - View application note |
Fast MAb analysis by Zenix SEC - View application note |
BevacizuMAb and Erbitux Antibodies by Zenix SEC-300 - View application note |
MAb Heavy chain and Light Chain Separation by Zenix SEC - View application note |
MAb Fragments Separation and Characterization by SEC and SEC/MS - View application note |
Fresh MAb Analysis on Zenix 300 - View application note |
Fast Separation of MAb and its Aggregates in Less Than 3 Mins - View application note |
High Loading of MAb Fragments on Zenix 300 - View application note |
Fast Separation of Horse Serum by Zenix - View application note |
MAb and its ADCs Separation on SEC - View application note |
MAb Half Body TCEP Disulfide reduction - View application note |
SEC Packing Chemistry Impact on MAb Separation - View application note |
ADC Analysis on Zenix-C SEC - View application note |
mPEG-peptide on Zenix and Zenix-C SEC - View application note |
Analysis of Exenatide and Pegylated Exenatide on Zenix and Zenix-C SEC - View application note |
Intact Glycoprotein Isoforms Separation on Proteomix SAX - View application note |
Fusion Protein Separation on Zenix and Zenix-C 300 - View application note |
HSA Fusion Protein Separation on Zenix and Zenix-C 300 - View application note |
Fusion Protein Separation on SEC and SAX - View application note |
Analysis of Fc Fusion Protein on Zenix vs. SRT - View application note |
DNA Separation on Zenix SEC-300 and Proteomix SAX - View application note |
Oligonucleotide Separation on SEC, IEX and RP Columns - View application note |
Pegylated BSA Separation on SEC and SAX - View application note |
Pegylated Protein Separation on SEC and SAX - View application note |
PEG Separation on Zenix SEC - View application note |
Membrane protein Aqpz in Octyl glucoside Detergent-SEC Analysis - View application note |
3 & 5 µm SEC on Separation Efficiency - View application note |
Improved Resolution on 3 µm SEC - View application note |
MW Calibration Curve on Zenix Phases - View application note |
Separation of Bio-Rad Protein Mixture by Zenix - View application note |
Separation of Protein Mixture by Zenix Phases - View application note |
Fast Assay Application on Zenix-300 - View application note |
Lysozyme Elution Profiles on Zenix - View application note |
Separation of E. Coli Lysate on Various Zenix Pore Sizes - View application note |
Separation of Proteins and Peptide on Zenix Mixture - View application note |
Light Scattering Detection of BSA on Zenix SEC-300 - View application note |
Life Time Test of Zenix 300 with High Salt at pH 8.5 - View application note |
Protein Separation on Zenix SEC-300 with HPLC and FPLC system - View application note |
PEG Separation on two Zenix Columns in Tandem - View application note |
Polystyrene Sulfonate Polymer Separations on SEC - View application note |
E. Coli Lysate separation on SEC, SAX and RP - View application note |
Fast MAb Analysis on Zenix SEC - Flow rate - View application note |
MAb/ADC Fragment Separation after IDeS Digestion - View application note |
Intact MAb, ADC and their Fragment Analysis with SEC-MS - View application note |
IgE and IgG Separation on Zenix SEC-300 - View application note |
Water Soluble Polymer Separation on SEC Columns - View application note |
Complex Protein Sample Mixtures Analysis on Sepax Columns - View application note |
Sepax SEC Analytical Column Loading Capacity - View application note |
Reduced MAb Separation on Zenix SEC-300 2.1x300 with LC/MS Volatile Buffer - View application note |
MAb Purification and Aggregates Removal on Generik MC30-HIC Butyl - View application note |
SEC-300 Overlay with Different Particle Sizes -QC standard overlays with 3, 5, 10 mm SEC-300, 7.8 x 300 mm - View application note |
EM1006 - Bispecific mAb SEC analysis - View application note |
Membrane protein Aqpz separation in Octyl glucoside - View application note |
Analytical Characterization of NIST MAb by Sepax SEC, HIC, RP and CEX - View application note |
Analytical Characterization of NIST MAb by Size Exclusion Chromatography - View application note |
Herceptin Analysis on ZenixTM SEC-300 (7830) - View application note |
Literature Reference: EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies - View application note |
Literature Reference: A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems - View application note |